{"id":"https://openalex.org/W4386955073","doi":"https://doi.org/10.1182/bloodadvances.2023010122","title":"The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study","display_name":"The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study","alternate_titles":[],"publication_year":2023,"publication_date":"2023-12-01","ids":{"openalex":"https://openalex.org/W4386955073","doi":"https://doi.org/10.1182/bloodadvances.2023010122","pmid":"https://pubmed.ncbi.nlm.nih.gov/37738125","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10711170"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2023010122","doi":"https://doi.org/10.1182/bloodadvances.2023010122","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023010122","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4386955073"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1182/bloodadvances.2023010122","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075183737","display_name":"Nobuko Hijiya","orcid":"https://orcid.org/0000-0002-0199-054X","observed_orcids":["https://orcid.org/0000-0002-0199-054X"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Nobuko Hijiya","raw_affiliation_strings":["1Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY","Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY, USA, United States"],"raw_orcid":"https://orcid.org/0000-0002-0199-054X","affiliations":[{"raw_affiliation_string":"1Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]},{"raw_affiliation_string":"Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY, USA, United States","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011971433","display_name":"Alexey Maschan","orcid":"https://orcid.org/0000-0002-0016-6698","observed_orcids":["https://orcid.org/0000-0002-0016-6698"]},"institutions":[{"id":"https://openalex.org/I4210127411","display_name":"Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology","ror":"https://ror.org/02h8dsx08","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210127411"]}],"countries":["RU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexey Maschan","raw_affiliation_strings":["2Dmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia","Dmtri Rogachev Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation"],"raw_orcid":"https://orcid.org/0000-0002-0016-6698","affiliations":[{"raw_affiliation_string":"2Dmitrii Rogachev Federal Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia","institution_ids":["https://openalex.org/I4210127411"]},{"raw_affiliation_string":"Dmtri Rogachev Research Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation","institution_ids":["https://openalex.org/I4210127411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057678079","display_name":"Carmelo Rizzari","orcid":"https://orcid.org/0000-0002-4828-3893","observed_orcids":["https://orcid.org/0000-0002-4828-3893"]},"institutions":[{"id":"https://openalex.org/I66752286","display_name":"University of Milano-Bicocca","ror":"https://ror.org/01ynf4891","country_code":"IT","type":"education","lineage":["https://openalex.org/I66752286"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carmelo Rizzari","raw_affiliation_strings":["3Pediatria, Fondazione IRCSS San Gerardo dei Tintori, Universit\u00e1 di Milano-Bicocca, Monza, Italy"],"raw_orcid":"https://orcid.org/0000-0002-4828-3893","affiliations":[{"raw_affiliation_string":"3Pediatria, Fondazione IRCSS San Gerardo dei Tintori, Universit\u00e1 di Milano-Bicocca, Monza, Italy","institution_ids":["https://openalex.org/I66752286"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043590671","display_name":"Hiroyuki Shimada","orcid":"https://orcid.org/0000-0002-5168-3222","observed_orcids":["https://orcid.org/0000-0002-5168-3222"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroyuki Shimada","raw_affiliation_strings":["4Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Japan"],"raw_orcid":"https://orcid.org/0000-0002-5168-3222","affiliations":[{"raw_affiliation_string":"4Department of Pediatrics, Keio University School of Medicine, Shinjuku-ku, Japan","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078527916","display_name":"Carlo Dufour","orcid":"https://orcid.org/0000-0002-5980-5474","observed_orcids":["https://orcid.org/0000-0002-5980-5474"]},"institutions":[{"id":"https://openalex.org/I2801463291","display_name":"Istituto Giannina Gaslini","ror":"https://ror.org/0424g0k78","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2801463291","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carlo Dufour","raw_affiliation_strings":["5Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Giannina Gaslini, Genova, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Giannina Gaslini, Genova, Italy","institution_ids":["https://openalex.org/I2801463291"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038338410","display_name":"Hiroaki Goto","orcid":"https://orcid.org/0000-0001-6737-1509","observed_orcids":["https://orcid.org/0000-0001-6737-1509"]},"institutions":[{"id":"https://openalex.org/I4210115195","display_name":"Kanagawa Children's Medical Center","ror":"https://ror.org/022h0tq76","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210115195"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroaki Goto","raw_affiliation_strings":["6Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan","institution_ids":["https://openalex.org/I4210115195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087839513","display_name":"Hyoung Jin Kang","orcid":"https://orcid.org/0000-0003-1009-6002","observed_orcids":["https://orcid.org/0000-0003-1009-6002"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]},{"id":"https://openalex.org/I4210104532","display_name":"Seoul National University Children's Hospital","ror":"https://ror.org/01ks0bt75","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388","https://openalex.org/I4210104532"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hyoung Jin Kang","raw_affiliation_strings":["10Wide River Institute of Immunology, Hongcheon-gun, South Korea","7Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea","8Seoul National University Cancer Research Institute, Seoul, South Korea","9Seoul National University Children's Hospital, Seoul, South Korea","10Wide River Institute of Immunology, Hongcheon-gun, South Korea; 7Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea; 9Seoul National University Children's Hospital, Seoul, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Wide River Institute of Immunology, Hongcheon-gun, South Korea","institution_ids":[]},{"raw_affiliation_string":"7Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea","institution_ids":["https://openalex.org/I139264467"]},{"raw_affiliation_string":"8Seoul National University Cancer Research Institute, Seoul, South Korea","institution_ids":["https://openalex.org/I139264467"]},{"raw_affiliation_string":"9Seoul National University Children's Hospital, Seoul, South Korea","institution_ids":["https://openalex.org/I4210104532"]},{"raw_affiliation_string":"10Wide River Institute of Immunology, Hongcheon-gun, South Korea; 7Department of Pediatrics, Seoul National University College of Medicine, Seoul, South Korea; 9Seoul National University Children's Hospital, Seoul, South Korea","institution_ids":["https://openalex.org/I139264467","https://openalex.org/I4210104532"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072650788","display_name":"Terri L. Guinipero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1314135232","display_name":"Nationwide Children's Hospital","ror":"https://ror.org/003rfsp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1314135232"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Terri Guinipero","raw_affiliation_strings":["11Nationwide Children's Hospital, The Ohio State University, Columbus, OH","Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11Nationwide Children's Hospital, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I1314135232","https://openalex.org/I52357470"]},{"raw_affiliation_string":"Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, United States","institution_ids":["https://openalex.org/I1314135232","https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058130927","display_name":"Zeynep Karaka\u015f","orcid":"https://orcid.org/0000-0002-8835-3235","observed_orcids":["https://orcid.org/0000-0002-8835-3235"]},"institutions":[{"id":"https://openalex.org/I4210112471","display_name":"Istanbul University-Cerrahpa\u015fa","ror":"https://ror.org/01dzn5f42","country_code":"TR","type":"education","lineage":["https://openalex.org/I4210112471"]},{"id":"https://openalex.org/I67581229","display_name":"Istanbul University","ror":"https://ror.org/03a5qrr21","country_code":"TR","type":"education","lineage":["https://openalex.org/I67581229"]}],"countries":["TR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Zeynep Karakas","raw_affiliation_strings":["12Pediatric Hematology/Oncology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey","Istanbul Medical Faculty, Pediatric Hematology/Oncology, Istanbul University, Istanbul, Turkey, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Pediatric Hematology/Oncology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey","institution_ids":["https://openalex.org/I4210112471","https://openalex.org/I67581229"]},{"raw_affiliation_string":"Istanbul Medical Faculty, Pediatric Hematology/Oncology, Istanbul University, Istanbul, Turkey, Turkey","institution_ids":["https://openalex.org/I67581229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052857128","display_name":"Francisco Jos\u00e9 Bautista","orcid":"https://orcid.org/0000-0002-0421-8862","observed_orcids":["https://orcid.org/0000-0002-0421-8862"]},"institutions":[{"id":"https://openalex.org/I4210111810","display_name":"Hospital Infantil Universitario Ni\u00f1o Jes\u00fas","ror":"https://ror.org/028brk668","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210111810","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4210127118","display_name":"Princess M\u00e1xima Center","ror":"https://ror.org/02aj7yc53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210127118"]}],"countries":["ES","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francisco Bautista","raw_affiliation_strings":["13Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Hospital Ni\u00f1o Jes\u00fas, Madrid, Spain","14Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-0421-8862","affiliations":[{"raw_affiliation_string":"13Department of Pediatric Oncology, Hematology and Stem Cell Transplantation, Hospital Ni\u00f1o Jes\u00fas, Madrid, Spain","institution_ids":["https://openalex.org/I4210111810"]},{"raw_affiliation_string":"14Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210127118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044244437","display_name":"St\u00e9phane Ducassou","orcid":"https://orcid.org/0000-0001-7736-0838","observed_orcids":["https://orcid.org/0000-0001-7736-0838"]},"institutions":[{"id":"https://openalex.org/I4210112727","display_name":"H\u00f4pital Pellegrin","ror":"https://ror.org/02x581406","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443","https://openalex.org/I4210112727"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"St\u00e9phane Ducassou","raw_affiliation_strings":["15Groupe Hospitalier Pellegrin-H\u00f4pital des Enfants, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Groupe Hospitalier Pellegrin-H\u00f4pital des Enfants, Bordeaux, France","institution_ids":["https://openalex.org/I4210112727"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068266757","display_name":"Keon Hee Yoo","orcid":"https://orcid.org/0000-0002-5980-7912","observed_orcids":["https://orcid.org/0000-0002-5980-7912"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keon Hee Yoo","raw_affiliation_strings":["16Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea","Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, Korea-Demo PeopleS Rep"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]},{"raw_affiliation_string":"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, Korea-Demo PeopleS Rep","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064026375","display_name":"Christian Michel Zwaan","orcid":"https://orcid.org/0000-0002-1353-9166","observed_orcids":["https://orcid.org/0000-0002-1353-9166"]},"institutions":[{"id":"https://openalex.org/I4210127118","display_name":"Princess M\u00e1xima Center","ror":"https://ror.org/02aj7yc53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210127118"]},{"id":"https://openalex.org/I4210142620","display_name":"Erasmus MC - Sophia Children\u2019s Hospital","ror":"https://ror.org/047afsm11","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4210142620"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christian Michel Zwaan","raw_affiliation_strings":["14Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands","17Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210127118"]},{"raw_affiliation_string":"17Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4210142620"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089621837","display_name":"Fr\u00e9d\u00e9ric Millot","orcid":"https://orcid.org/0000-0002-8912-4776","observed_orcids":["https://orcid.org/0000-0002-8912-4776"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210111187","display_name":"Centre Hospitalier Universitaire de Poitiers","ror":"https://ror.org/029s6hd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210111187"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fr\u00e9d\u00e9ric Millot","raw_affiliation_strings":["18Unit\u00e9 d'Onco-H\u00e9matologie P\u00e9diatrique, Centre d'Investigation Clinique (CIC) 1402 INSERM, Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"18Unit\u00e9 d'Onco-H\u00e9matologie P\u00e9diatrique, Centre d'Investigation Clinique (CIC) 1402 INSERM, Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210111187"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047469126","display_name":"Briana Cary Patterson","orcid":"https://orcid.org/0000-0001-9992-5596","observed_orcids":["https://orcid.org/0000-0001-9992-5596"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4210146983","display_name":"Children's Healthcare of Atlanta","ror":"https://ror.org/050fhx250","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210146983"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Briana C. Patterson","raw_affiliation_strings":["19Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"19Aflac Cancer and Blood Disorders Center, Children\u2019s Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4210146983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034468827","display_name":"Jill H. Samis","orcid":"https://orcid.org/0000-0001-9369-1661","observed_orcids":["https://orcid.org/0000-0001-9369-1661"]},"institutions":[{"id":"https://openalex.org/I1294278766","display_name":"Lurie Children's Hospital","ror":"https://ror.org/03a6zw892","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1294278766"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jill Samis","raw_affiliation_strings":["20Ann and Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL","Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States"],"raw_orcid":"https://orcid.org/0000-0001-9369-1661","affiliations":[{"raw_affiliation_string":"20Ann and Robert H. Lurie Children\u2019s Hospital of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I1294278766"]},{"raw_affiliation_string":"Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States","institution_ids":["https://openalex.org/I1294278766"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075656335","display_name":"Miguel Angel Izquierdo","orcid":"https://orcid.org/0000-0002-3596-928X","observed_orcids":["https://orcid.org/0000-0002-3596-928X"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Miguel Izquierdo","raw_affiliation_strings":["21Novartis Pharma AG, Basel, Switzerland","Novartis Pharma AG, Basel, Switzerland, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"21Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029807054","display_name":"Ksenia Titorenko","orcid":"https://orcid.org/0000-0002-5379-388X","observed_orcids":["https://orcid.org/0000-0002-5379-388X"]},"institutions":[{"id":"https://openalex.org/I4210086790","display_name":"Novartis (Germany)","ror":"https://ror.org/0013shd50","country_code":"DE","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210086790"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ksenia Titorenko","raw_affiliation_strings":["22Novartis Pharmaceuticals Corporations, Munich, Germany","Novartis Pharmaceuticals Corporations, Munich, Germany, Germany"],"raw_orcid":"https://orcid.org/0000-0002-5379-388X","affiliations":[{"raw_affiliation_string":"22Novartis Pharmaceuticals Corporations, Munich, Germany","institution_ids":[]},{"raw_affiliation_string":"Novartis Pharmaceuticals Corporations, Munich, Germany, Germany","institution_ids":["https://openalex.org/I4210086790"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100326558","display_name":"Sai Li","orcid":"https://orcid.org/0000-0002-7091-1454","observed_orcids":["https://orcid.org/0000-0002-7091-1454"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sai Li","raw_affiliation_strings":["21Novartis Pharma AG, Basel, Switzerland","Novartis Pharma AG, Basel, Switzerland, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"21Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]},{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087541392","display_name":"Darintr Sosothikul","orcid":"https://orcid.org/0000-0003-1097-3482","observed_orcids":["https://orcid.org/0000-0003-1097-3482"]},"institutions":[{"id":"https://openalex.org/I158708052","display_name":"Chulalongkorn University","ror":"https://ror.org/028wp3y58","country_code":"TH","type":"education","lineage":["https://openalex.org/I158708052"]}],"countries":["TH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Darintr Sosothikul","raw_affiliation_strings":["23Intergrative and Innovative Hematology/Oncology Research Unit, Division of Hematology/Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"],"raw_orcid":"https://orcid.org/0000-0003-1097-3482","affiliations":[{"raw_affiliation_string":"23Intergrative and Innovative Hematology/Oncology Research Unit, Division of Hematology/Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand","institution_ids":["https://openalex.org/I158708052"]}]}],"institutions":[],"countries_distinct_count":12,"institutions_distinct_count":26,"corresponding_author_ids":["https://openalex.org/A5075183737"],"corresponding_institution_ids":["https://openalex.org/I2799503643"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":2.0471,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.87168635,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"7","issue":"23","first_page":"7279","last_page":"7289"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":1.0},{"id":"https://openalex.org/keywords/pediatric-chronic-myeloid-leukemia","display_name":"pediatric chronic myeloid leukemia","score":0.9449999928474426},{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-chronic-myeloid-leukemia","display_name":"Philadelphia chromosome-positive chronic myeloid leukemia","score":0.9269999861717224},{"id":"https://openalex.org/keywords/chronic-phase","display_name":"chronic phase","score":0.7170000076293945},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.7829999923706055},{"id":"https://openalex.org/keywords/dasatinib-resistance","display_name":"dasatinib resistance","score":0.9459999799728394},{"id":"https://openalex.org/keywords/newly-diagnosed-cml","display_name":"newly diagnosed CML","score":0.765999972820282},{"id":"https://openalex.org/keywords/major-molecular-response","display_name":"major molecular response","score":0.8130000233650208},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.7850000262260437},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.8429999947547913},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.9786036014556885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8698186278343201},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.7134062051773071},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6803669929504395},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.6749026775360107},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6128630638122559},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5034052729606628},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.3521447777748108}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1182/bloodadvances.2023010122","doi":"https://doi.org/10.1182/bloodadvances.2023010122","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023010122","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10711170","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10711170","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10711170/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:37738125","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37738125","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"},{"id":"pmh:oai:pure.eur.nl:openaire/436de48c-29e1-4e39-a827-fc1130466e5f","doi":null,"is_oa":true,"landing_page_url":"https://pure.eur.nl/en/publications/436de48c-29e1-4e39-a827-fc1130466e5f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hijiya, N, Maschan, A, Rizzari, C, Shimada, H, Dufour, C, Goto, H, Kang, H J, Guinipero, T, Karakas, Z, Bautista, F, Ducassou, S, Yoo, K H, Zwaan, C M, Millot, F, Patterson, B C, Samis, J, Izquierdo, M, Titorenko, K, Li, S & Sosothikul, D 2023, 'The long-term efficacy and safety of nilotinib in pediatric patients with CML : a 5-year update of the DIALOG study', Blood Advances, vol. 7, no. 23, pp. 7279-7289. https://doi.org/10.1182/bloodadvances.2023010122","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2023010122","doi":"https://doi.org/10.1182/bloodadvances.2023010122","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2023010122","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4386955073.pdf","grobid_xml":"https://content.openalex.org/works/W4386955073.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1852848770","https://openalex.org/W1965561480","https://openalex.org/W2030109982","https://openalex.org/W2053105417","https://openalex.org/W2053566054","https://openalex.org/W2062710544","https://openalex.org/W2099172974","https://openalex.org/W2124196948","https://openalex.org/W2137149985","https://openalex.org/W2137591261","https://openalex.org/W2166654361","https://openalex.org/W2171589158","https://openalex.org/W2260921597","https://openalex.org/W2791994878","https://openalex.org/W2809367512","https://openalex.org/W2950424869","https://openalex.org/W2951926078","https://openalex.org/W2952357575","https://openalex.org/W2973170708","https://openalex.org/W2982867602","https://openalex.org/W3119368005","https://openalex.org/W3183346817","https://openalex.org/W3214345487","https://openalex.org/W3216367044","https://openalex.org/W4242044105","https://openalex.org/W4250795086"],"related_works":["https://openalex.org/W2973170708","https://openalex.org/W3183346817","https://openalex.org/W4417431461","https://openalex.org/W4230456545","https://openalex.org/W2951926078","https://openalex.org/W3003884964","https://openalex.org/W2791143140","https://openalex.org/W2009746825","https://openalex.org/W4214769469","https://openalex.org/W2518361291"],"abstract_inverted_index":{"The":[0,138,172],"efficacy":[1,41,197],"and":[2,42,71,88,111,146,157,163,165,198],"safety":[3,43,173,199],"of":[4,55,118,136,175,181,200],"nilotinib":[5,58,176,201],"in":[6,23,29,159,167,202],"pediatric":[7,203],"patients":[8,47,68,113,131,204],"with":[9,57,179,205],"imatinib/dasatinib":[10],"resistant/intolerant":[11],"(R/I)":[12],"or":[13,63],"newly":[14],"diagnosed":[15],"(ND)":[16],"Philadelphia":[17],"chromosome-positive":[18],"(Ph+)":[19],"chronic":[20,24],"myeloid":[21],"leukemia":[22],"phase":[25,31],"(CML-CP)":[26],"was":[27,109,128,177,210],"demonstrated":[28],"the":[30,93,96,123,160,168,196],"2,":[32],"open-label":[33],"DIALOG":[34],"study.":[35],"In":[36,92],"this":[37],"final":[38],"analysis,":[39],"long-term":[40,189],"are":[44],"presented":[45],"for":[46],"who":[48],"completed":[49],"66":[50,153],"cycles":[51,154],"(of":[52],"28":[53],"days)":[54],"treatment":[56],"(230":[59],"mg/m2":[60],"twice":[61],"daily)":[62],"discontinued":[64],"early.":[65],"Overall,":[66],"59":[67],"were":[69,73,155],"enrolled":[70],"58":[72],"treated":[74],"(R/I,":[75],"n":[76,80],"=":[77,81],"33;":[78],"ND,":[79],"25;":[82],"median":[83],"time":[84],"on":[85],"treatment:":[86],"60.5":[87],"51.9":[89],"months,":[90],"respectively).":[91],"R/I":[94,161],"cohort,":[95,162,170],"cumulative":[97,139],"major":[98],"molecular":[99,140],"response":[100,141],"(MMR;":[101],"BCR::ABL1":[102],"international":[103],"scale":[104],"[IS]":[105],"\u2264":[106,144,149],"0.1%)":[107],"rate":[108,127],"60.6%,":[110],"no":[112],"had":[114,132],"a":[115,133],"confirmed":[116,134],"loss":[117,135],"MMR.":[119,137],"Among":[120],"ND":[121,169],"patients,":[122],"best":[124],"overall":[125],"MMR":[126],"76.0%;":[129],"3":[130],"MR4":[142],"(BCR::ABL1IS":[143,148],"0.01%)":[145],"MR4.5":[147],"0.0032%)":[150],"rates":[151],"by":[152],"27.3%":[156],"12.1%":[158],"56.0%":[164],"44.0%":[166],"respectively.":[171],"profile":[174],"consistent":[178],"those":[180],"earlier":[182],"reports.":[183],"No":[184],"on-treatment":[185],"deaths":[186],"occurred.":[187],"These":[188],"(up":[190],"to":[191],"\u223c5":[192],"years)":[193],"data":[194],"support":[195],"Ph+":[206],"CML-CP.":[207],"This":[208],"trial":[209],"registered":[211],"at":[212],"www.clinicaltrials.gov.uk":[213],"as":[214],"#NCT01844765.":[215]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4386955073","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2023-09-23T00:00:00"}
